Drug conjugates-an emerging approach to treat breast cancer.

Hasan, Mahmud; Leak, Rehana K; Stratford, Robert E; Zlotos, Darius P; Witt-Enderby, Paula A

Hasan, Mahmud; Leak, Rehana K; Stratford, Robert E; Zlotos, Darius P; Witt-Enderby, Paula A.

Afiliação

Hasan M; Division of Pharmaceutical, Administrative, and Social Sciences Duquesne University Pittsburgh PA USA.
Leak RK; Division of Pharmaceutical, Administrative, and Social Sciences Duquesne University Pittsburgh PA USA.
Stratford RE; Indiana University School of Medicine Indianapolis IN USA.
Zlotos DP; Department of Pharmaceutical Chemistry The German University in Cairo New Cairo City Cairo Egypt.
Witt-Enderby PA; Division of Pharmaceutical, Administrative, and Social Sciences Duquesne University Pittsburgh PA USA.

Pharmacol Res Perspect ; 6(4): e00417, 2018 07.

Article em En | MEDLINE | ID: mdl-29983986

Assuntos

Antineoplásicos/administração & dosagem; Neoplasias da Mama/tratamento farmacológico; Animais; Combinação de Medicamentos; Quimioterapia Combinada; Humanos

Palavras-chave

breast cancer; drug conjugates; hybrid ligands; nanoparticles

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google